Authors: HUTCHINSON RJ NEERHOUT RC BERTOLONE S COOPER HA ROSKOS R TANNOUS R WELLS L HEEREMA N HUMMELL D SAILER S SATHER H TRIGG M

Citation: Rj. Hutchinson et al., SHOULD THERAPY BE INTENSIFIED FOR PATIENTS WITH GOOD RISK ALL, Blood, 88(10), 1996, pp. 2662-2662

Authors: BENNETTS G BERTOLONE S BRAY G DINNDORF P FEUSNER J CAIRO M

Citation: G. Bennetts et al., ERYTHROPOIETIN REDUCES VOLUME OF RED-CELL TRANSFUSIONS REQUIRED IN SOME SUBSETS OF CHILDREN WITH ACUTE LYMPHOCYTIC-LEUKEMIA, Blood, 86(10), 1995, pp. 3401-3401

Authors: BUTLER D JOSE B SUMME R PARIS K BERTOLONE S PATEL CC SPANOS W LINDBERG R

Citation: D. Butler et al., PEDIATRIC ASTROCYTOMAS - THE LOUISVILLE EXPERIENCE - 1978-1988, American journal of clinical oncology, 17(6), 1994, pp. 475-479

Authors: SENDER L JAKACKI R MONTES V PATEL C KREISSMAN S BERTOLONE S

Citation: L. Sender et al., ANALYSIS OF 150 PEDIATRIC PERIPHERAL STEM-CELL PHERESIS CELL PRODUCTSOBTAINED FROM PEDIATRIC-PATIENTS UNDERGOING REPEATED CYCLES OF NON-MYELOABLATIVE HIGH-DOSE CHEMOTHERAPY - IMPLICATIONS FOR CD34+ PERIPHERALTRANSFUSIONS, Blood, 82(10), 1993, pp. 10000641-10000641